PMC:7534795 / 0-228 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T65995","span":{"begin":24,"end":35},"obj":"Body_part"}],"attributes":[{"id":"A79782","pred":"fma_id","subj":"T65995","obj":"http://purl.org/sig/ont/fma/fma82738"}],"text":"Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?\n\nAbstract\nCoronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":83,"end":91},"obj":"Disease"},{"id":"T2","span":{"begin":143,"end":167},"obj":"Disease"},{"id":"T3","span":{"begin":169,"end":177},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?\n\nAbstract\nCoronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T98443","span":{"begin":50,"end":51},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?\n\nAbstract\nCoronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":8,"end":35},"obj":"Chemical"},{"id":"T2","span":{"begin":24,"end":35},"obj":"Chemical"},{"id":"T3","span":{"begin":30,"end":35},"obj":"Chemical"},{"id":"T4","span":{"begin":62,"end":70},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_35366"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":"Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?\n\nAbstract\nCoronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome "}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":132},"obj":"Sentence"},{"id":"T2","span":{"begin":134,"end":142},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?\n\nAbstract\nCoronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome "}

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":4,"end":35},"obj":"Chemical"},{"id":"4","span":{"begin":83,"end":91},"obj":"Disease"},{"id":"5","span":{"begin":103,"end":131},"obj":"Disease"},{"id":"52","span":{"begin":143,"end":167},"obj":"Disease"},{"id":"53","span":{"begin":169,"end":177},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"MESH:D015525"},{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"MESH:C000657245"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:D002318"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"MESH:C000657245"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?\n\nAbstract\nCoronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome "}